ZYUS Life Sciences Corporation

Research ZYUS Life Sciences Corporation (ZYUS) on Bullrun: market cap CAD 40.04M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerZYUS
• ExchangeV
• CountryCanada
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyCAD
• Market capCAD 40.04M
• Financial periodQ3 2025
• RevenueCAD 105.00K
• Net income-CAD 3.62M
• Free cash flow-CAD 2.53M
• Gross margin-3.8%

Valuation Snapshot

latest market cap is CAD 40.04M.

About ZYUS Life Sciences Corporation

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.

Frequently asked questions

What is ZYUS Life Sciences Corporation's market cap?

ZYUS Life Sciences Corporation's market capitalization is CAD 40.04M.

What does ZYUS Life Sciences Corporation do?

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.